Accelovance Inc.

Accelovance Inc., headquartered in Rockville, MD, has a proven approach to accelerating clinical development that delivers study Sponsors optimal  results through greater control and productivity. Our staff performance,  predictable enrollment, and executive focus produce cost- effective solutions to address our clients’ needs as they define them.

Accelovance provides flexible CRO services that are tailored to meet our clients’ needs. Our experienced team creates strategic solutions that meet protocol endpoints and objectives, while addressing the unique challenges presented in each study we undertake.

Accelovance owns and operates 7 research-dedicated Clinical Sites located within the United States. Our sites have been selected to work directly with study Sponsors, both pharmaceutical and biotech, and have been selected by CROs. In addition, our sites work with Accelovance’s own CRO team to maximize efficiencies and gain unprecedented control over research programs. Our site teams receive standardized training that includes a 22-section internally developed study coordinator manual, ICH/GCP, and good documentation practices. Our sites are optimized for research – they average 3,000 square feet, manage a database that includes over 50,000 active study volunteers, and have dedicated refrigeration and freezers.

USA
Corporate Headquarters
2275 Research Blvd. Suite 700 Rockville, MD 20850 USA